Skip to main content

Diabetes and Metabolism

The Diabetes and Metabolism Research Group is search is lead by Dr. Rafael Simó (Hirsch index:54), Head of the Endocrinology Department, Professor of Medicine & Endocrinology at UAB and current President of the European Association for the Study of Diabetes-Eye Complications. The group consists of 7 senior clinical investigators, 4 basic post-doctoral researchers, 4 pre-doc researchers, 3 laboratory technicians and one coordinator of clinical assays.  

The group belongs to “CIBER” of Diabetes and Associated Metabolic Diseases (CIBERDEM. ISCIII) and has been recognized as consolidated group by the Generalitat de Catalunya (AQU/AGAUR).

Since 2014 this group has been qualified as outstanding in the evaluations performed by the ANEP, CIBERDEM and the external Scientific Advisory Board of VHIR. 

The main lines of research are:

  • Complications of diabetes (in particular diabetic retinopathy)
  • Obesity and its co-morbidities
  • Type 2 diabetes and cognitive impairment
  • Thyroid diseases
  • Hospital Nutrition. 

Team

Betina Biagetti Biagetti

Betina Biagetti Biagetti

Senior researcher
Diabetes and Metabolism
Read more
Carles Zafon Llopis

Carles Zafon Llopis

Main researcher
Diabetes and Metabolism
Read more
Cristina Hernández Pascual

Cristina Hernández Pascual

Main researcher
Diabetes and Metabolism
Read more
David Martinez Selva

David Martinez Selva

Main researcher
Diabetes and Metabolism
Read more
Elia Rojas Montserrat

Elia Rojas Montserrat

Administration and Management
Diabetes and Metabolism
Read more
Fernanda Mucarzel Suarez-Arana

Fernanda Mucarzel Suarez-Arana

Research technician
Diabetes and Metabolism
Read more
Betina Biagetti Biagetti

Betina Biagetti Biagetti

Senior researcher
Diabetes and Metabolism
Read more
Carles Zafon Llopis

Carles Zafon Llopis

Main researcher
Diabetes and Metabolism
Read more
Cristina Hernández Pascual

Cristina Hernández Pascual

Main researcher
Diabetes and Metabolism
Read more
David Martinez Selva

David Martinez Selva

Main researcher
Diabetes and Metabolism
Read more
Elia Rojas Montserrat

Elia Rojas Montserrat

Administration and Management
Diabetes and Metabolism
Read more
Fernanda Mucarzel Suarez-Arana

Fernanda Mucarzel Suarez-Arana

Research technician
Diabetes and Metabolism
Read more

Projects

DESARROLLO DE EDL6D, UN PÉPTIDO MIMÉTICO DE SHBG PARA EL TRATAMIENTO DE LA ENFERMEDAD DEL HÍGADO GRASO NO ALCOHÓLICO (NAFLD) Y LA ESTEATOHEPATITIS NO ALCOHÓLICA (NASH)

IP: David Martinez Selva
Collaborators: Lidia Fuertes Rioja
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 370568
Reference: CPP2022-009831
Duration: 01/07/2023 - 30/06/2026

Ministerio de Ciencia

Topical administration of sitagliptin in experimental models of diabetic retinopathy and glaucoma: delving into mechanisms of action and changing the therapeutic positioning (“Sit@Retina”).

IP: Rafael Simó Canonge
Collaborators: Maria Llorian Salvador
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 321250
Reference: PID2022-138544OB-I00
Duration: 01/09/2023 - 31/08/2026

Ministerio de Ciencia

OBESIMM - Explorando los efectos de la alimentación restringida en el tiempo sobre la funcióin inmune de individuos obesos: una aproximación multi-ómica

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz, Andreea Ciudin Mihai, Marta Comas Martinez, Ramón Vilallonga Puy, Enzamaría Fidilio Meli
Funding agency: Instituto de Salud Carlos III
Funding: 248050
Reference: AC22/00023
Duration: 01/01/2023 - 30/06/2026

(INFLAMWAT) - Mecanismos involucrados en la resolución de la inflamación del tejido adiposo en respuesta a restricción calórica

IP: Josep A Villena Delgado
Collaborators: Angel Michael Ortiz Zúñiga, Laura Hidalgo Corbacho, Alba Rojano Toimil, Ramón Vilallonga Puy
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 217800
Reference: PID2021-123377OB-I00
Duration: 01/09/2022 - 31/08/2026

Ministerio de Ciencia
Blog

News

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.